Familial autoimmune myasthenia gravis: report of four families

Evoli, A; Batocchi, A P; Zelano, G; Uncini, A; Palmisani, M T; Tonali, P
June 1995
Journal of Neurology, Neurosurgery & Psychiatry;Jun1995, Vol. 58 Issue 6, p729
Academic Journal
journal article
No abstract available.


Related Articles

  • Familial autoimmune MuSK positive myasthenia gravis. Corda, Davide; Deiana, Giovanni A.; Mulargia, Marina; Pirastru, Maria I.; Serra, Maria; Piluzza, Maria G.; Carcassi, Carlo; Sechi, GianPietro // Journal of Neurology;Aug2011, Vol. 258 Issue 8, p1559 

    A letter to the editor is presented regarding the medical case of a family from Sardinia, Italy with history of autoimmune myasthenia gravis (MG) with anti-acethylcholine receptor antibodies (AChR Ab).

  • Coexistence Of Myasthenia Gravis And Myotonic Dystrophy In A Thyrotoxicosis Patient. Karagoz, E. T.; Midi, I.; Tanridag, T. // Internet Journal of Neurology;2008, Vol. 9 Issue 1, p8 

    A 28 year old previously healthy female presented with a four month history of difficulty of swallowing and drinking liquids and proximal weakness with fluctuation. At her physical examination, she had bilateral exophtalmus which were compatible with hyperthyroidism. Her facial appearance,...

  • Myasthenia Gravis Presenting as Dysphagia: Clinical Considerations. Khan, Omar A.; Campbell, William W. // American Journal of Gastroenterology;Jul1994, Vol. 89 Issue 7, p1083 

    Myasthenia gravis is an autoimmune disorder of the neuromuscular junction that causes muscle weakness. Involvement of oropharyngeal musculature is not uncommon, which leads to dysphagia. Timely consideration of myasthenia gravis in evaluating dysphagia is crucial to prevent complications and to...

  • Coexistence of autoimmune diseases and autoantibodies in patients with myasthenia gravis. Pandit, Lekha // Neurology India;Jan/Feb2016, Vol. 64 Issue 1, p7 

    The author reflects on the coexistence of autoimmune diseases with a greater prevalence rate within individuals and in families. Topics covered include the percentage of the population affected by autoimmune disorders, the manifestation of myasthenia gravis during the course of the neurological...

  • Myasthenia Gravis and Auto-immune Disease. Piemme, Thomas E. // Annals of Internal Medicine;Jan64, Vol. 60 Issue 1, p130 

    Presents a review of literature about myasthenia gravis and autoimmune disease and a case report of the coexistence of myasthenia and systemic lupus erythematosus. Clinical characteristics of myasthenia; Patient case background; Treatment.

  • Survivin as a Potential Mediator to Support Autoreactive Cell Survival in Myasthenia Gravis: A Human and Animal Model Study. Kusner, Linda L.; Ciesielski, Michael J.; Marx, Alexander; Kaminski, Henry J.; Fenstermaker, Robert A. // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    The mechanisms that underlie the development and maintenance of autoimmunity in myasthenia gravis are poorly understood. In this investigation, we evaluate the role of survivin, a member of the inhibitor of apoptosis protein family, in humans and in two animal models. We identified survivin...

  • High dose cyclophosphamide for severe refractory myasthenia gravis. Gladstone, D. E.; Brannagan III, T. H.; Schwartzman, R. J.; Prestrud, A. A.; Brodsky, I. // Journal of Neurology, Neurosurgery & Psychiatry;May2004, Vol. 75 Issue 5, p789 

    Presents a letter to the editor about myasthenia gravis an autoimmune disease.

  • Penicillamine induced myasthenia reactivated by gold. Moore, A.P.; Williams, A.C.; Hillenbrand, P. // British Medical Journal (Clinical Research Edition);1/21/1984, Vol. 288 Issue 6412, p192 

    Presents a case report of a reactivated penicillamine induced myasthenia gravis by gold. Clinical feature of the patient; Mechanism of action of penicillamine in inducing autoimmune disorders; Caution in prescribing gold to patient with penicillamine induced myasthenia.

  • Azathioprine.  // Reactions Weekly;8/24/2013, Issue 1466, p10 

    An abstract of the article "A case of familial myasthenia gravis and azathioprine-induced bone marrow toxicity in multiple family members," by B. Marky and colleagues is presented.

  • Statin-associated weakness in myasthenia gravis: a case report. Keogh, Michael J.; Findlay, John M.; Leach, Simon; Bowen, John // Journal of Medical Case Reports;2010, Vol. 4 Issue 1, p1 

    Introduction: Myasthenia gravis is a commonly undiagnosed condition in the elderly. Statin medications can cause weakness and are linked to the development and deterioration of several autoimmune conditions, including myasthenia gravis. Case presentation: We report the case of a 60-year-old...


Read the Article


Sign out of this library

Other Topics